Cargando…

The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo

BACKGROUND: Non-communicable diseases (NCDs) are an emerging global public health problem. OBJECTIVES: To assess the prevalence of NCDs and their risk factors among adults on antiretroviral therapy (ART). METHOD: This was a cross-sectional study (July 2019 – January 2020) in Limpopo, South Africa. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebina, Limakatso, Malatji, Tumiso, Nabeemeeah, Firdaus, Motsomi, Kegaugetswe, Siwelana, Tsundzukani, Hlongwane, Khuthadzo, Martinson, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546900/
https://www.ncbi.nlm.nih.gov/pubmed/37795429
http://dx.doi.org/10.4102/sajhivmed.v24i1.1495
_version_ 1785114954312974336
author Lebina, Limakatso
Malatji, Tumiso
Nabeemeeah, Firdaus
Motsomi, Kegaugetswe
Siwelana, Tsundzukani
Hlongwane, Khuthadzo
Martinson, Neil
author_facet Lebina, Limakatso
Malatji, Tumiso
Nabeemeeah, Firdaus
Motsomi, Kegaugetswe
Siwelana, Tsundzukani
Hlongwane, Khuthadzo
Martinson, Neil
author_sort Lebina, Limakatso
collection PubMed
description BACKGROUND: Non-communicable diseases (NCDs) are an emerging global public health problem. OBJECTIVES: To assess the prevalence of NCDs and their risk factors among adults on antiretroviral therapy (ART). METHOD: This was a cross-sectional study (July 2019 – January 2020) in Limpopo, South Africa. Patients were enrolled if they were ≥ 40 years, HIV-positive, and virologically suppressed on ART. Data were analysed descriptively, and a binomial regression model was used to identify risk factors for NCDs. RESULTS: The majority of participants (65%; 319/488) were women. Most (83%; 405/488) were aged 40–59 years; 60% (285/472) were overweight or obese. Based on self-report, 22% (107/488) were currently smokers. Almost half (44%) 213/488) reported daily consumption of vegetables and 65% (319/488) exercised regularly and 39% (190/488) reported treatment for another chronic disease. The leading comorbid conditions were hypertension (32%; 158/488) and diabetes mellitus (5%; 24/488). Risk factors for hypertension included age 60 years and older (relative risk [RR]: 1.72; 95% confidence interval [CI]: 1.29–2.30) diabetes (RR: 1.42; 95% CI: 1.08–1.87), overweight (RR: 1.32; 95% CI: 1.03–1.69) and obesity (RR: 1.69; 95% CI: 1.32–2.17). CONCLUSION: There is a high prevalence, both of risk factors for NCDs and multimorbidity (> 1 chronic disease) in patients who are ≥ 40 years and virologically suppressed on ART.
format Online
Article
Text
id pubmed-10546900
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-105469002023-10-04 The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo Lebina, Limakatso Malatji, Tumiso Nabeemeeah, Firdaus Motsomi, Kegaugetswe Siwelana, Tsundzukani Hlongwane, Khuthadzo Martinson, Neil South Afr J HIV Med Original Research BACKGROUND: Non-communicable diseases (NCDs) are an emerging global public health problem. OBJECTIVES: To assess the prevalence of NCDs and their risk factors among adults on antiretroviral therapy (ART). METHOD: This was a cross-sectional study (July 2019 – January 2020) in Limpopo, South Africa. Patients were enrolled if they were ≥ 40 years, HIV-positive, and virologically suppressed on ART. Data were analysed descriptively, and a binomial regression model was used to identify risk factors for NCDs. RESULTS: The majority of participants (65%; 319/488) were women. Most (83%; 405/488) were aged 40–59 years; 60% (285/472) were overweight or obese. Based on self-report, 22% (107/488) were currently smokers. Almost half (44%) 213/488) reported daily consumption of vegetables and 65% (319/488) exercised regularly and 39% (190/488) reported treatment for another chronic disease. The leading comorbid conditions were hypertension (32%; 158/488) and diabetes mellitus (5%; 24/488). Risk factors for hypertension included age 60 years and older (relative risk [RR]: 1.72; 95% confidence interval [CI]: 1.29–2.30) diabetes (RR: 1.42; 95% CI: 1.08–1.87), overweight (RR: 1.32; 95% CI: 1.03–1.69) and obesity (RR: 1.69; 95% CI: 1.32–2.17). CONCLUSION: There is a high prevalence, both of risk factors for NCDs and multimorbidity (> 1 chronic disease) in patients who are ≥ 40 years and virologically suppressed on ART. AOSIS 2023-09-18 /pmc/articles/PMC10546900/ /pubmed/37795429 http://dx.doi.org/10.4102/sajhivmed.v24i1.1495 Text en © 2023. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Lebina, Limakatso
Malatji, Tumiso
Nabeemeeah, Firdaus
Motsomi, Kegaugetswe
Siwelana, Tsundzukani
Hlongwane, Khuthadzo
Martinson, Neil
The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo
title The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo
title_full The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo
title_fullStr The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo
title_full_unstemmed The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo
title_short The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo
title_sort prevalence of multimorbidity in virally suppressed hiv-positive patients in limpopo
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546900/
https://www.ncbi.nlm.nih.gov/pubmed/37795429
http://dx.doi.org/10.4102/sajhivmed.v24i1.1495
work_keys_str_mv AT lebinalimakatso theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT malatjitumiso theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT nabeemeeahfirdaus theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT motsomikegaugetswe theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT siwelanatsundzukani theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT hlongwanekhuthadzo theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT martinsonneil theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT lebinalimakatso prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT malatjitumiso prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT nabeemeeahfirdaus prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT motsomikegaugetswe prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT siwelanatsundzukani prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT hlongwanekhuthadzo prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo
AT martinsonneil prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo